Insider Trading & Ownership - Shendelman Shoshana

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Shendelman Shoshana
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-08-12
Sale
2024-08-14
7:01 pm
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
777,014 $6.0643 $4,712,049 7,309,496
(Indirect
Direct)
View
2024-06-06
Sale
2024-06-10
4:29 pm
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
61,795 $4.32 $266,954 8,086,510
(Indirect
Direct)
View
2024-03-14
Sale
2024-03-18
6:12 pm
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
318,573 $5.39 $1,717,108 8,148,305
(Indirect
Direct)
View
2023-11-30
Sale
2023-12-01
7:42 pm
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
3,968 $1.97 $7,817 6,926,878
(Indirect
Direct)
View
2023-09-27
Sale
2023-09-29
8:03 pm
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
115,632 $2.7 $312,206 6,930,846
(Indirect
Direct)
View
2023-01-11
Sale
2023-01-13
4:34 pm
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
15,870 $0.91 $14,442 7,046,478
(Indirect
Direct)
View
2022-10-14
Purchase
2022-10-14
5:41 pm
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
50,000 $0.645 $32,250 5,097,986
(Indirect
Direct)
View
2022-10-13
Purchase
2022-10-13
6:17 pm
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
73,256 $0.5582 $40,891 5,047,986
(Indirect
Direct)
View
2022-10-12
Purchase
2022-10-12
8:51 pm
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
38,153 $0.5227 $19,943 4,974,730
(Indirect
Direct)
View
2021-09-13
Purchase
2021-09-14
4:44 pm
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
10,001 $14.5 $145,038 4,694,777
(Indirect
Direct)
View
2020-07-20
Sale
2020-07-22
9:55 pm
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
45,000 $26.68 $1,200,789 6,548,603
(Indirect
Direct)
View
2020-07-07
Sale
2020-07-09
9:55 pm
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
45,000 $31.86 $1,433,796 5,973,871
(Indirect
Direct)
View
2020-05-28
Sale
2020-06-01
7:52 pm
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
125,000 $42.7 $5,337,500 5,224,101
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-08-05
Gift
2024-08-14
7:01 pm
N/A
N/A
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
1,495,772 $0 7,309,496
(Indirect)
View
2023-12-21
Option Award
2023-12-22
8:01 pm
N/A
N/A
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
1,540,000 $0 8,466,878
(Direct)
View
2023-01-11
Option Award
2023-01-13
4:34 pm
N/A
N/A
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
1,964,362 $0 7,046,478
(Direct)
View
2022-01-25
Option Award
2022-01-27
6:32 pm
N/A
2032-01-25
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
234,616 $0 234,616
(Direct)
View
2022-01-07
Option Award
2022-01-11
6:45 pm
N/A
2032-01-07
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
201,500 $0 5,017,177
(Direct)
View
2021-12-14
Option Award(A)
2022-01-11
6:42 pm
N/A
N/A
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
120,900 $0 4,815,677
(Direct)
View
2021-12-14
Option Award
2021-12-16
8:30 pm
N/A
2031-12-14
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
201,500 $0 4,896,277
(Direct)
View

Ownership
2021-02-16
9:52 pm
N/A
N/A
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
0 $0 4,684,836
(Indirect)
View
2020-10-02
Ownership
2021-02-16
9:52 pm
N/A
N/A
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
200,000 $0 4,684,836
(Direct)
View
2020-12-10
Option Award
2020-12-14
9:44 pm
N/A
2030-12-10
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
256,850 $0 256,850
(Direct)
View

Ownership
2020-11-13
6:16 pm
N/A
N/A
180 Life Sciences Corp. ATNF Shendelman Shoshana
Director
0 $0 0
(Direct)
View
2020-07-20
Exercise
2020-07-22
9:55 pm
N/A
2028-03-07
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
45,000 $0 6,548,603
(Direct)
View
2020-07-20
Exercise
2020-07-22
9:55 pm
N/A
N/A
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
45,000 $1.44 6,548,603
(Direct)
View
2020-07-07
Exercise
2020-07-09
9:55 pm
N/A
2028-03-07
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
45,000 $0 5,973,871
(Direct)
View
2020-07-07
Exercise
2020-07-09
9:55 pm
N/A
N/A
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
45,000 $1.44 5,973,871
(Direct)
View
2020-05-28
Exercise
2020-06-01
7:52 pm
N/A
N/A
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
27,624 $1 5,224,101
(Direct)
View
2020-05-28
Exercise
2020-06-01
7:52 pm
N/A
2027-03-27
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
125,000 $0 5,224,101
(Direct)
View
2020-02-28
Gift
2020-06-01
7:52 pm
N/A
N/A
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
1,000,000 $0 5,224,101
(Direct)
View
2020-05-28
Exercise
2020-06-01
7:52 pm
N/A
N/A
Applied Therapeutics Inc. APLT Shendelman Shoshana
President and CEO
10% Owner
97,376 $1.44 5,224,101
(Direct)
View
(A) Indicate amendment filing.